These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25452848)

  • 1. Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening.
    Cubiella J; Castro I; Hernandez V; González-Mao C; Rivera C; Iglesias F; Alves MT; Cid L; Soto S; De-Castro L; Vega P; Hermo JA; Macenlle R; Martínez A; Estevez P; Cid E; Herreros-Villanueva M; Portillo I; Bujanda L; Fernández-Seara J;
    United European Gastroenterol J; 2014 Dec; 2(6):522-9. PubMed ID: 25452848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
    Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
    Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
    Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
    Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.
    Katsoula A; Paschos P; Haidich AB; Tsapas A; Giouleme O
    JAMA Intern Med; 2017 Aug; 177(8):1110-1118. PubMed ID: 28628706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening.
    Alvarez-Urturi C; Andreu M; Hernandez C; Perez-Riquelme F; Carballo F; Ono A; Cruzado J; Cubiella J; Hernandez V; Mao CG; Perez E; Salas D; Andrés M; Bujanda L; Portillo I; Sarasqueta C; Quintero E; Morillas JD; Lanas A; Sostres C; Augé JM; Castells A; Bessa X;
    Dig Liver Dis; 2016 May; 48(5):542-551. PubMed ID: 26936343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.
    Hijos-Mallada G; Lué A; Velamazan R; Saura N; Abril C; Lorenzo M; Navarro M; Chueca E; Arechavaleta S; Gomollón F; Lanas Á; Sostres C
    Front Med (Lausanne); 2021; 8():665786. PubMed ID: 34150803
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance.
    Navarro M; Hijos G; Sostres C; Lué A; Puente-Lanzarote JJ; Carrera-Lasfuentes P; Lanas A
    Front Med (Lausanne); 2020; 7():410. PubMed ID: 32984360
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing sampling device for the fecal immunochemical test increases colonoscopy yields in colorectal cancer screening.
    Huang Y; Li Q; Ge W; Hu Y; Cai S; Yuan Y; Zhang S; Zheng S
    Eur J Cancer Prev; 2016 Mar; 25(2):115-22. PubMed ID: 25768975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from Thailand.
    Aniwan S; Ratanachu Ek T; Pongprasobchai S; Limsrivilai J; Praisontarangkul OA; Pisespongsa P; Mairiang P; Sangchan A; Sottisuporn J; Wisedopas N; Kullavanijaya P; Rerknimitr R
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):405-412. PubMed ID: 28345822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test.
    Cha JM; Lee JI; Joo KR; Shin HP; Park JJ; Jeun JW; Lim JU
    Digestion; 2012; 86(4):283-7. PubMed ID: 23051697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
    Haug U; Hundt S; Brenner H
    Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.